Chronix Biomedical logo — Pioneering new horizons in diagnosing and managing chronic d...

Chronix Biomedical

Pioneering new horizons in diagnosing and managing chronic diseases and cancer through innovative DNA-based assays.

Founded 1997 Venture round Total: $21.50M Biotechnology, Health Care

General Information

Company Name Chronix Biomedical
Founded Year 1997
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Chronix Biomedical. To contact Chronix Biomedical, visit chronixbiomedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Chronix Biomedical compare?

A PDF of Chronix Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Chronix Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Chronix Biomedical

Chronix Biomedical is a biotechnology startup that aims to revolutionize the diagnosis and management of chronic diseases and cancer through innovative DNA-based assays. Founded in 1997, the company is based in San Jose, California, with research facilities in Germany. Chronix Biomedical's unique technology involves measuring and categorizing circulating nucleic acids—DNA sequences found in the blood that are linked to specific changes in disease and health status. The startup is focused on collaborating with various partners to develop and market its DNA-based assays, which have the potential to significantly impact the management of numerous cancers and other conditions. The company recently secured a $3.31M Venture Round investment on 18 July 2017. The innovative approach and potential impact of Chronix Biomedical's technology make it a compelling investment opportunity within the biotechnology and healthcare industries.

Business keywords: DNA-based assays, diagnosis, management, chronic diseases, cancer, nucleic acids, innovation, biomedical research, oncology, proprietary technology, biotech startup, precision medicine, San Jose

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $3.31M -
18 Jul 2017
Venture Round $5.01M -
31 Oct 2016
Venture Round $3.43M -
08 Apr 2014
Venture Round $1.42M 1
PrairieGold Venture Partners
31 Oct 2012
Venture Round Undisclosed 1
VA Angels
01 Jan 2012
Venture Round $2.78M -
11 Mar 2011
Series E $1.80M -
20 Sep 2010
Venture Round $1.49M -
03 Nov 2009
Series B $2.27M 2
PrairieGold Venture Partners, Pentagram
05 Aug 2008
Seed Round Undisclosed 1
Boston Harbor Angels
01 Jun 2004

Chronix Biomedical Alternatives & Competitors

View All Alternatives
Chronix Biomedical vs

Pioneering precision immunomodulation to tackle chronic and acute inflammatory disorders at their so...

Grant
Biotechnology, Health Care
Chronix Biomedical vs
Aniling
Aniling Spain

Accelerating Epigenomics for Precision Medicine against cancer

Seed
12 employees
Biotechnology, Health Care
Chronix Biomedical vs

Pioneering early cancer diagnosis through advanced fluid biopsy technology

Series A
11-50 employees
Biotechnology, Health Care

FAQ About Chronix Biomedical

Pioneering new horizons in diagnosing and managing chronic diseases and cancer through innovative DNA-based assays.
Chronix Biomedical was founded in 1997.
Chronix Biomedical operates in Biotechnology and Health Care. Its work centres on DNA-based assays, diagnosis, management and chronic diseases.
Chronix Biomedical has completed 10 funding rounds, raising a total of $21.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Chronix Biomedical include Alivio Therapeutics, Aniling, ARNA Genomics, Viracta Therapeutics, Inc., Chimeron Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chronix Biomedical and Alivio Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chronix Biomedical, https://bouncewatch.com/company/chronix-biomedical, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes